Skip to main content

stock

MREO · Mereo BioPharma Group plc

What Mereo BioPharma Group plc reports to the SEC, read from its filings.

Open in the app

Price

The live MREO price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on MREO.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
798,454,864 as of 2026-08-07 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
194.3%
ROA
160.3%

Health

Current ratio
5.9x
Debt/equity
—

Deep value

NCAV
$27.34M
NCAV per share
$0.03
Price/NCAV
Locked
NNWC
$24.06M
NNWC per share
$0.03
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30$0—Gross profit: unreported by this company.-$7.03M-$7.00M
10-Q filed 2026-08-11
2026-03-31——Gross profit: unreported by this company.-$8.77M-$6.72M
10-Q filed 2026-08-11
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31——Gross profit: unreported by this company.-$8.39M$76.41M
DEF 14A filed 2026-04-09
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30$0—Gross profit: unreported by this company.-$10.02M-$7.02M
10-Q filed 2025-11-10
2025-06-30$500,000—Gross profit: unreported by this company.-$10.50M-$14.62M
10-Q filed 2026-08-11
2025-03-31——Gross profit: unreported by this company.-$11.20M-$12.89M
10-Q filed 2026-08-11
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31$0—Gross profit: unreported by this company.-$15.28M$79.46M
DEF 14A filed 2026-04-09
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30$0—Gross profit: unreported by this company.-$9.37M-$15.00M
10-Q filed 2025-11-10
Assets
$34.71M
Equity
$28.65M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$500,000-$40.11M$41.88M-$30.99M
2024-12-31$0-$47.36M$43.25M-$32.83M
2023-12-31$10.00M-$28.42M$29.47M-$21.13M
2022-12-31$0-$54.43M-$42.22M-$48.83M

Company filings

events

  • Listing standard notice

    Listing standard notice
    Aug 198-K
  • Results

    Results
    Aug 118-K
  • Material agreement, Regulation FD disclosure

    Material agreementRegulation FD disclosure
    Aug 118-K
  • Shareholder vote results

    Shareholder vote results
    May 148-K
  • Results

    Results
    May 128-K/A
  • Acquisition or sale completed

    Acquisition or sale completed
    May 128-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named MREO, and the market events around them.

Sign in to see this

Board

The MREO board could not be loaded.

Retry the MREO board

nakagai

Signals on MREO come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the MREO board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Mereo BioPharma Group plc (MREO): SEC filings, financials and insider trades · Nakagai